Zacks Rating on Gevo (GEVO)

Gevo (GEVO) : 1 brokerage houses believe that Gevo (GEVO) is a Strong Buy at current levels. 1 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on Gevo (GEVO). Zacks Investment Research suggests a Buy with a rank of 2.The median of all the 2 Wall Street Analysts endorse the stock as a Buy with a rating of 2.

Gevo (GEVO) : 2 Wall Street analysts covering Gevo (GEVO) believe that the average level the stock could reach for the short term is $2.5. The maximum price target given is $4 and the minimum target for short term is around $1, hence the standard deviation is calculated at $2.12.


Gevo, Inc. has lost 0.87% in the last five trading days and dropped 4.47% in the last 4 weeks. Gevo, Inc. is up 54.53% in the last 3-month period. Year-to-Date the stock performance stands at -15.26%. Gevo (NASDAQ:GEVO): On Tuesdays trading session , Opening price of the stock was $0.54 with an intraday high of $0.54. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $0.5201. However, the stock managed to close at $0.5254, a loss of 0.36% for the day. On the previous day, the stock had closed at $0.5273. The total traded volume of the day was 1,619,389 shares.

Gevo, Inc. (Gevo) is a renewable chemicals and biofuels company. The Compnay is focused on the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The Company operates through two segments: the Gevo, Inc. and the Gevo Development/Agri-Energy. The Gevo, Inc. segment is responsible for all research and development activities related to the production of isobutanol, including the development of its biocatalysts, the production and sale of biojet fuel. The Gevo Development/Agri-Energy Segment is responsible for the operation of its Agri-Energy Facility and the production of ethanol, isobutanol and related products.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.